| Smiles |
O=C1(NC(C(=O)NC(C(=O)N4(C(C(=O)NC(C(O)C(=O)NC(C(=O)NCC(N3(C(C(NC(C(NC(C(NC(C(NC1=CC)=O)CO)=O)C(C)C)=O)CC2(=CC=CC=C2))=O)CCC3))=O)CCC(=O)N)CC(OC(=O)C(N(C(=O)CCC)C)C)CC(O)C(O)CC(C)C)CCC4))CCC5(=CC=C(OC)C=C5))CO)
|
| CAS number |
160325-99-5
|
| Polar Surface Area |
502,6
|
| calculated LogS |
-5,689
|
| Molweight |
1490,71
|
| calculated LogP |
-2,0044
|
| H-Acceptors |
34
|
| H-Donors |
15
|
| Ro5 violations |
3
|
| Druglikeness |
8,2659
|
| DrugScore |
0,333372
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Fish Toxicity |
High FHMT
|
| Fish Toxicity2 |
1,306
|
| Rat Acute Toxicity |
3,0138
|
| Acute Oral Toxicity |
III
|
| Caco-2 Permeability |
Caco2-
|
| Caco-2 Permeability2 |
0,0411
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor |
Non-inhibitor
|
| P-glycoprotein Inhibitor2 |
Non-inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition2 |
Inhibitor
|
| CYP450 2C9 Substrate |
Non-substrate
|
| Tetrahymena Pyriformis Toxicity |
High TPT
|
| Tetrahymena Pyriformis Toxicity2 |
0,5749
|
| AMES Toxicity |
Non AMES toxic
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Substrate |
Non-substrate
|
| Biodegradation |
Not ready biodegradable
|
| Carcinogens |
Non-carcinogens
|
| Blood-Brain Barrier |
BBB-
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Honey Bee Toxicity |
Low HBT
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Carcinogenicity (Three-class) |
Non-required
|
| Human Intestinal Absorption |
HIA+
|
| Structure |
160325-99-5
|
